Brief: Athira Pharma Provides Update On Plans For Ongoing Lift-Ad Clinical Study Of Fosgonimeton In Mild-To-Moderate Alzheimer’S Patients

LeonaBio

06/09/2022 12:46

Sept 6 (Reuters) - Athira Pharma Inc  ATHA.O :
    * ATHIRA PHARMA PROVIDES UPDATE ON PLANS FOR ONGOING LIFT-AD
CLINICAL STUDY OF FOSGONIMETON IN MILD-TO-MODERATE ALZHEIMER’S
PATIENTS
    * ATHIRA PHARMA INC - CONDUCTING AN INDEPENDENT, UNBLINDED
INTERIM
ANALYSIS TO CONFIRM SAMPLE SIZE FOR PRIMARY ENDPOINT OF GLOBAL
STATISTICAL TEST (GST)
    * ATHIRA PHARMA INC - OVERALL DESIGN OF LIFT-AD REMAINS
UNCHANGED,
INCLUDING GLOBAL STATISTICAL TEST AS PRIMARY ENDPOINT

Source text for Eikon:  ID:nGNXcgyyCr 
Further company coverage:  ATHA.O 

 (Reporting by Pratik Jain)
 ((Pratik.Jain@thomsonreuters.com;))